1-9 of 9
Bradley Augustson, MBBS, FRACP, FRCPA
Close
Sort by
Journal Articles

Combination of Idasanutlin, Venetoclax and Obinutuzumab in Patients with Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Results from a Phase I/II Study

Manali Kamdar, MD, Bradley Augustson, MBBS FRACP FRCPA, Young Rok Do, PhDMD, James Edwards, Mark Hertzberg, MBBS PhDFRACP FRCPA, Amanda Johnston, FRACP,FRCPA,MBBS,BMBS,MD, Jin Seok Kim, MD PhD, Frank P. Kroschinsky, MDMBA, Sonali M. Smith, MD, Don A. Stevens, MD, Annabelle Monnet, Ye Zhao, Yann Nouet, PhD MSc, Viktoriya Marinova
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-136221
Published: 2020
Journal Articles

Carfilzomib Thalidomide and Dexamethasone Is Safe and Effective in the Treatment of Relapsed/Refractory Multiple Myeloma: An Open Label Phase II Australasian Leukaemia and Lymphoma Group (ALLG) MM 018/ Asian Myeloma Network (AMN) 002 Study

Hang Quach, MD, Simon J Harrison, MBBS MRCP (UK) PhDFRCPath (UK) FRACP, Je-Jung Lee, MD PhD, Nichloas Murphy, MBBS, FRACP, FRCPA, Jae Hoon Lee, MD PhD, Kim Kihyun, MD, Jane Estell, FRACP, Noemi Horvath, MB ChB FRACP FRCPA, Richard Eek, FRACP., Bradley Augustson, MBBS FRACP FRCPA, Philip Campbell, MBBS, Rajeev Rajagopal, FRACP, Soo-Mee Bang, MDPhD, Jeffrey SY Huang, MD, PhD, Yoon Sung Soo, MD PhD, Belinda Butcher, BSci, MBiostat, PhD, Brian G.M. Durie, MD, Wee Joo Chng, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-139174
Published: 2020
Journal Articles

Detection of Del(17p) in Hematological Malignancies By Imaging Flow Cytometry

Wendy N. Erber, MD, Henry Hui, PhD, Jason Stanley, BSc (Hons), Thomas Mincherton, BSc, Kathryn Clarke, PhD, Bradley Augustson, MBBS FRACP FRCPA, Teng Fong Ng, BSc, MBBS, MRCP, Chan Yoon Cheah, MBBS, Andrew David McQuillan, MBBS, FRACP, FRCPA, Kathy Fuller, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-143323
Published: 2020
Journal Articles

DREAMM-6: Safety, Tolerability and Clinical Activity of Belantamab Mafodotin (Belamaf) in Combination with Bortezomib/Dexamethasone (BorDex) in Relapsed/Refractory Multiple Myeloma (RRMM)

Rakesh Popat, Ajay Nooka, MDMPH, Keith Stockerl-Goldstein, MD, Rafat Abonour, MD, Ryan Ramaekers, MD, Amit Khot, MD, Adam Forbes, MD, Cindy Lee, MD, Bradley Augustson, MBBS FRACP FRCPA, Andrew Spencer, Maria-Victoria Mateos, MD PhD, Bikramjit Chopra, PhD, Rachel Rogers, MS, Deborah A Smith, PharmD, Jacqueline Davidge, PhD, Rocio Montes de Oca, PhD, Geraldine Ferron-Brady, PhD, Anne Yeakey, MD, Mala Talekar, MD, Brandon E. Kremer, MD PhD, Ira Gupta, MD, Hang Quach, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-139332
Published: 2020
Journal Articles

Real-World Outcome for Newly Diagnosed Patients with Functional High-Risk Myeloma - a Myeloma and Related Diseases Registry Analysis

Andrew Spencer, MBBS, FRACP, FRCPA, DM, Peter Mollee, MBBS, MMSc, FRACP, FRCPA, Hilary Anne Blacklock, FRACP, Simon Harrison, MBBS, MRCP, FRCPath, FRACP, PhD, Hang Quach, MBBS, FRACP, FRCPA, MD, P. Joy Ho, MBBS DPhil FRACP FRCPA, Ruth Spearing, MD, Jay Hocking, MBBS, FRACP, FRCPA, Bradley Augustson, MBBS FRACP FRCPA, H. Miles Prince, MBBS (Hons), MD FRACP, FRCPA, AFRCMA, MACD, Elizabeth M. Moore, PhD, Zoe McQuilten, Erica M. Wood, MBBS, FRACP, FRCPA, Cameron Wellard
Journal: Blood
Blood (2019) 134 (Supplement_1): 269.
https://doi.org/10.1182/blood-2019-129431
Published: 2019
Journal Articles

Survival of Patients with Multiple Myeloma in Western Australia, a Large State of 2.5 Million Square Kilometers: A Population Based Study

Teng Fong Ng, BSc, MBBS, MRCP, Michael F. Leahy, MBChB, FRACP, FRCPath, FRCP, Bradley Augustson, MBBS FRACP FRCPA, Sally Burrow, BMATH GradDipMedStat, Philip Vlaskovsky, BSc, PGDipSci, MSc, Ben Carnley, MBBS, FRACP, FRCPA, Matthew P.F. Wright, MBBS, FRCPA, FRACP
Journal: Blood
Blood (2018) 132 (Supplement 1): 3552.
https://doi.org/10.1182/blood-2018-99-112148
Published: 2018
Journal Articles

Carfilzomib Thalidomide and Dexamethasone Is Safe and Effective in the Treatment of Relapsed/Refractory Multiple Myeloma: Preliminary Outcome from the Open Label Phase II ALLGMM018/AMN003 Study

Hang Quach, MDFRACP,FRCPA,MBBS, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, Slavisa Ninkovic, MBBS FRACP FRCPA, Jane Estell, MBBS FRACP, Noemi Horvath, MBBS FRACP FRCPA, Nick Murphy, MBBS FRACP FRCPA, Richard Eek, MBCHB, Bradley Augustson, MBBS FRACP FRCPA, Philip Campbell, MBBS, FRACP, FRCPA, Rajeev Rajagopal, Akash Kalro, MD, Robyn Hemme, Belinda Butcher, BSc(Hons) MBiostat PhDCMPP AStat, Tracey Gerber, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Brian GM Durie, MD, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 1955.
https://doi.org/10.1182/blood-2018-99-111434
Published: 2018
Journal Articles

A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis

Efstathios Kastritis, MD, Xavier Leleu, MD, Bertrand Arnulf, Elena Zamagni, MD, Peter Mollee, M Teresa Cibeira, Stefan O Schönland, Philippe Moreau, MD, Roman Hajek, Arnaud Jaccard, MD, Emmanuelle Nicolas-Virelizier, MD, Robin Filshie, PhD FRACP, Bradley Augustson, MBBS, FRACP, FRCPA, Maria-Victoria Mateos, MD PhD, Paolo Milani, MD, Meletios A. Dimopoulos, Eric Hachulla, MD PhD, Jean-Paul Fermand, MD PhD, Andrea Foli, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD, Hans Erik Johnsen, MD, Giampaolo Merlini, MD, Giovanni Palladini, MD PhD
Journal: Blood
Blood (2014) 124 (21): 35.
https://doi.org/10.1182/blood.V124.21.35.35
Published: 2014
Journal Articles

A Prognostic Nomogram for Diffuse Large B Cell Lymphoma Incorporating the International Prognostic Index with Interim-PET Findings,

Annie W.S. Chow, MBBS, Teck Siew, MBBS, FRANZCR, Michael Phillips, M.Med.Sci, Mitchell Steve Ward, MB, ChB, FRCP, FRACP, FRCPA, Bradley Augustson, MBBS, FRACP, FRCPA, Gavin Cull, MBBS, DM, FRACP, FRCPA, David Joske, MBBS, FRCPA, FRACP
Journal: Blood
Blood (2011) 118 (21): 3664.
https://doi.org/10.1182/blood.V118.21.3664.3664
Published: 2011